Rocket Pharmaceuticals Inc
RCKT
ISIN null / Valor 39764376
Rocket Pharmaceuticals Inc
UMushroom community rating:
About company
Rocket Pharmaceuticals Inc. is a New York–based, Nasdaq‑listed clinical‑stage biotechnology company developing gene therapies for rare, inherited pediatric diseases. The firm advances both ex vivo lentiviral approaches—principally via genetically modified hematopoietic stem cells—and in vivo AAV‑based therapies, with clinical programs targeting hematologic, neuromuscular and cardiac genetic disorders. In addition to advancing multiple clinical candidates, Rocket operates internal vector manufacturing and development capabilities to support its trials and regulatory filings, positioning itself as a developer of durable, one‑time genetic interventions for severe monogenic conditions.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
424 M
Market cap (USD)
888,541
Daily traded volume (Shares)
12.25 / 11.56
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Pascale Gonzalez
EQUITIES OF THE SAME SECTOR
